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Objective: People with diabetes are prone to develop lower-extremity ulcerations and
infections, both of which serve as major risk factors for limb amputation. The devel-
opment of lower-extremity complications of diabetes is associated with increased mor-
bidity and mortality. Recently, there has been increasing interest in the development of
interdisciplinary teams to manage the myriad factors that complicate the treatment of
high-risk patients, particularly in the perihospitalization period. Methods: This article
presents 7 essential skills that necessarily allow the limb salvage team to appropriately
manage the most common presenting comorbidities in patients with diabetes, includ-
ing vasculopathy, infection, and deformity. Results: Seven essentials skills have been
demonstrated to promote the greatest salvage outcomes, and these are the ability to
(1) perform hemodynamic and anatomic vascular assessment with revascularization, as
necessary; (2) perform neurologic workup; (3) perform site-appropriate culture tech-
nique; (4) perform wound assessment and staging/grading of infection and ischemia;
(5) perform site-specific bedside and intraoperative incision and debridement; (6) initi-
ate and modify culture-specific and patient-appropriate antibiotic therapy; and (7) per-
form appropriate postoperative monitoring to reduce risk of reulceration and infection.
Conclusions: Utilization of these 7 essential skills as the core basis for interdisciplinary
limbsalvageteammodelswillprovidecliniciansguidancewhenestablishingsuchteams.
Interdisciplinary teams have been demonstrated to improve quality and efficiency of pa-
tient care, thus improving overall outcomes and reducing amputation rates.
The incidence of diabetes mellitus worldwide has reached almost epidemic propor-
tions, with nearly 26 million people affected by the disease in the United States alone.1,2
In concert with this increased incidence, there has been a significant rise in the observed
comorbidities commonly associated with the disease process in patients with diabetes.3,4
Among these complications, lower-extremity manifestations are a significant source of
patient comorbidity, mortality, and healthcare expense. It has been estimated that the life-
time risk of developing diabetic foot ulceration (DFU) is as high as 25% in patients with
diabetes.1,5 In addition to the development of DFU, more than 50% of these ulcerations will
becomeinfected,accountingfornearly20%ofalldiabetes-relatedhospitaladmissions,and
therefore a significant portion of healthcare related costs—nearly $11 billion—in 2001.6
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In patients with infected DFUs, underlying osteomyelitis is observed in as many as
65% of cases, and these infected ulcers constitute a major risk factor for nontraumatic
lower-extremity amputation (LEA).5 Indeed, nearly 83% of all nontraumatic LEAs in the
UnitedStatesaresecondarytocomplicationsassociatedwithdiabetesmellitus.5 Ithasbeen
well documented that the consequences of major LEA in diabetic patients are severe, with
an estimated 5-year postoperative survival rate of less than 50%, suggesting, in fact, that
mortality associated with diabetic LEAs exceeds that of most cancers.7 It is therefore vital
to provide early and effective diagnosis and management of patients with lower-extremity
complications of diabetes in an effort to stem the current epidemic of limb loss.
Considering that the pathophysiology of lower-extremity limb loss in patients with
diabetes is multifactorial and that vasculopathy and neuropathy are critical contributors,
it is appropriate to utilize an interdisciplinary team approach to specifically address the
varyingfactorsthatcombinetocreatelower-extremityulceration,infection,andsubsequent
amputation. Such interdisciplinary models have been demonstrated to be highly effective
in reducing the incidence of nontraumatic amputations in the diabetic population. A search
of the literature reveals that little has been published on the requisite skill sets of the
interdisciplinary team to promote limb preservation in patients with diabetes. The authors
have defined 7 vital abilities that a diabetic rapid response acute foot team (DRRAFT)
should have in its armamentarium so that it might effectively manage the lower-extremity
complications of diabetes.8
THE TEAM
The diabetic rapid response acute foot team is an interdisciplinary team model whose core
involves the ability to rapidly diagnose and provide effective treatment to patients with
lower-extremity complications of diabetes, utilizing seven basic skill sets. The authors have
previously advocated that the “irreducible minimum” regarding interdisciplinary units be
oriented around treatment teams that are staffed by members of the vascular surgery and
podiatric surgery specialties, with adjunctive team members being added as necessary via
judicioususeofconsultation.9TheDRRAFTconceptisthenaturalextensionofthispremise:
Bringing the nuances from each individual specialty, the team collectively must possess the
abilitytoperform7essentialskillstobeeffectiveinpromotinglimbpreservation.However,
any clinician involved in the care of the diabetic patient with a passion for limb salvage can
function as a member of the DRRAFT limb salvage team. Indeed, often times, geographic
limitation will require that requisite team member roles be performed by physicians trained
in global wound care, advanced practice nurses, or clinical nurse specialists.
SEVEN ESSENTIAL SKILLS
The management of the lower-extremity manifestations of diabetes mellitus is a complex
task, and it is necessary that practitioners involved in diabetic limb salvage address both the
systemic and local factors that interact to generate significant comorbidity and mortality
in this patient population. The major factors include vasculopathy and neuropathy, often in
combination with foot deformity, and lead to the development of DFUs.10–12 The literature
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is clear that infected diabetic ulcerations present a major risk factor for LEA and therefore
it is necessary to appropriately manage DFUs when they occur, including addressing the
underlyingetiologyaswellasdealingwithaninfectionthatmaybepresent.13Sevenessential
skills have been identified, and are detailed in the following text, which can be utilized in
combination by DRRAFT members to effectively manage DFUs when they occur and
prevent progression to LEA.
1. Theabilitytoperformhemodynamicandanatomicvascularassessmentwithrevas-
cularization, as necessary.
Patients with diabetes often suffer from peripheral arterial disease with elements of
microvascular and macrovascular diseases,14,15 although it is predominantly macrovas-
cular disease that produces critical limb ischemia. Patients with critical limb ischemia
are at significant risk for limb loss and require timely intervention to improve distal
lower-extremity perfusion.16 Among patients with both vascular compromise and lower-
extremity ulceration, it is necessary to address the patient’s vascular status in order to
promote effective wound healing and to reduce amputation risk.
Itisvital,therefore,thatDRRAFTmembershavereadilyathandthecapabilitytorapidly
assess the lower-extremity circulation and potential for healing by noninvasive means.
Although physical examination and handheld Doppler evaluation by an experienced
clinician are extremely important, objective testing of lower-extremity perfusion is fre-
quently required and can be accomplished by toe Doppler waveform analysis and toe
pressure determinations, transcutaneous oxygen pressure (TcPO2) measurements, and
arterial duplex ultrasound. Depending on the results of these studies and the response
of the index wound to care, further testing such as computed tomography angiography
or magnetic resonance angiography may be indicated, although conventional arteriogra-
phy is often preferred once a hemodynamic state insufficient to heal the foot has been
documented, since a therapeutic procedure (angioplasty or stent placement) can be of-
ten performed at the same sitting as diagnostic arteriography.17–19 Early arteriography
and rapid revascularization either by endovascular means or open surgical bypass are
needed in patients with DFUs who have inadequate perfusion to limit persistent limb
ischemia and subsequent tissue loss and to provide sufficiently increased distal flow
to promote wound healing.16 Delays in the recognition and treatment of macrovascular
occlusive disease compromise outcomes, delay wound healing, prolong hospital stays,
and unnecessarily increase the risk of major limb amputation.14
2. The ability to perform neurologic workup.
Diabetic patients often develop neurologic symptoms as a consequence of long-standing
hyperglycemia; these include motor, sensory, and autonomic neuropathy.10,11,20 These
symptomsareinvolvedatmanylevelsinthedevelopmentoflower-extremityulcerations.
Perhaps, most widely recognized of the neurologic symptoms common to diabetics is
sensory neuropathy with loss of protective sensation (LOPS).21 These patients lose the
“gift of pain.” In the absence of pain, diabetic patients are far more likely to develop
ulcerationsduetoLOPSinthecontextofincreasedshearandpressureforces.Inaddition,
motor neuropathy in the intrinsic musculature can lead to muscle imbalance, which
creates foot deformity that, in conjunction with sensory neuropathy, can lead to the
development of areas of increased forces that can progress to ulceration.
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It is fundamental that DRRAFT members be able to appropriately evaluate the patient’s
neurologic status to establish LOPS via sensory neuropathy, as well as any concomitant
elements of motor or autonomic neuropathy that can contribute to the development of
lower-extremity ulceration.1 Loss of protective sensation can be evaluated via the 5.07
Semmes-Weinstein monofilament test, which is utilized to evaluate sensory perception
at 10 locations along the dorsal and plantar aspects of the foot, and has been shown to
demonstratea97%sensitivityanda83%specificityinidentifyingpatientsathighestrisk
for diabetic foot ulcers.22 Motor neuropathy can be determined by evaluating muscular
strengthinthevariousmusclegroupsinthelowerextremity.Thediagnosisofneuropathy
is important because it correlates with the risk of recurrence, dictates the intensity and
type of follow-up that will be required, and mandates ongoing attention to prevention by
regular assessment of footwear and attention to proper offloading.
3. The ability to perform site-appropriate culture technique.
When presented with infected lower-extremity ulcerations, the clinician must be able
to reliably obtain useful culture data. The literature demonstrates that lower-extremity
infections of diabetes are often polymicrobial, with an average of 2.25 pathogens per
patient.23 Furthermore,resultsofsuperficialswabculturestakenfromawoundarenoto-
riously unreliable; one study demonstrated that superficial swabs of infected ulcerations
identified deep soft-tissue pathogens in only 75% of cases.24 It is necessary that suitable
deep culture specimens from a wound should be obtained to appropriately direct antibi-
otictherapy.StaphylococcusaureusandStaphylococcusepidermidis,Enterococcus,and
Streptococcus species, particularly group B, β hemolytic, are most commonly observed;
however, in this era of increasing drug-resistant organisms, methicillin-resistant S. au-
reus is being identified more and more frequently, especially in patients with diabetes.23
In addition, aerobic gram-negative rods (Pseudomonas aeruginosa being the most com-
mon) and obligate anaerobe species have also been observed in many cases, although
their pathogenicity is not clear. Lavery et al25 reported that only 36% of soft-tissue
cultures yielded accurate bone pathogens; therefore, in those instances in which un-
derlying osteomyelitis is suspected, bone biopsy is recommended in addition to deep
soft-tissue cultures to increase the likelihood of accurately identifying the appropriate
causative microorganisms.23,26 Cultures of pathogens should be harvested before the
patient receives any antibiotics, if at all possible, since this may affect the reliability of
the specimen.
4. The ability to perform wound assessment and staging/grading of infection and
ischemia.
When evaluating lower-extremity ulcerations in the diabetic population, it is vital that
practitioners be able to speak a lingua franca, or “common language,” regarding these
wounds. Numerous classification systems have been proposed that seek to provide this
common language; perhaps, the most universal is the University of Texas Diabetic Foot
Wound Classification System (Fig 1). This system provides a uniform basis for describ-
ing lower-extremity diabetic ulceration with regard to depth of wound and the presence
(or absence) of ischemia and infection.27,28 Extending from grade 0 to grade 3, the depth
of the wound is described, with increasing depth of the wound noted as one moves along
the horizontal axis. In this classification system, wounds are further staged according
to the presence of infection, ischemia, or both. Utilization of validated classification
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Figure 1. University of Texas Diabetic Foot Wound Classification System.27
Figure 2. Infection classification systems.
systems, such as the University of Texas Diabetic Foot Wound Classification System,
can allow DRRAFT members to transcend the language of their particular specialties to
effectively describe lower-extremity diabetic wounds.27 While the University of Texas
system is useful for describing the ulceration itself, it may not be specific enough if
infection is the primary presentation. Both the International Working Group on the Di-
abetic Foot and the Infectious Diseases Society of America Diabetic Foot Guidelines
Committee have independently developed very similar infection staging systems that
are mostly interchangeable and have recently been statistically validated (Fig 2). These
systems stage infection on the basis of severity of infection presentation and from this
clinical description suggest which the most common pathogenic organisms are and rec-
ommend empiric antibiotic therapy. American Diabetes Association (ADA) guidelines
are included in number 7 in the following text, and Figure 3 represents ADA guide-
lines/classification.
5. The ability to perform site-speciﬁc bedside and intraoperative incision and
debridement.
Following appropriate assessment of vascular status and assessment of potential infec-
tion, it is necessary that DRRAFT members be able to provide timely incision and
drainage to decompress areas of abscess formation as well as to provide appropriate
debridement to remove all infected, nonviable, and necrotic soft tissue and bone. Such
debridement limits the proximal spread of infection, obtains deep specimens for culture,
and allows for tissue demarcation in the zones of tissue compromise.11
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Figure 3. Diabetic foot risk classification system. LOPS indicates loss of protective sensation;
PAD, peripheral arterial disease.21,22
Numerous authors have advocated the use of debridement in the management of lower-
extremity infection, and it plays a vital role in diabetic limb salvage.14,29–31 Appropriate
wound debridement is the starting point on the continuum of wound healing, and re-
moval of necrotic, nonviable tissue down to a bleeding base is necessary to allow for
woundbedpreparationandtheformationofhealthygranulartissue.32 Furthermore,soft-
tissue debridement is useful in stimulating quiescent cells observed in chronic wounds.
Appropriate and timely tissue debridement is essential in turning the tide of infection
and setting the patient down the path toward reconstructive efforts, wound healing, and
functional limb preservation.33,34
6. Theabilitytoinitiateandmodifyculture-speciﬁcandpatient-appropriateantibiotic
therapy.
To effectively control infection in the diabetic patient, it is vital that appropriate wound
cultures be obtained.23 Patients with almost all mild and some moderate infections can
be treated with oral antibiotics with fairly specific activity against aerobic gram-positive
organisms. Patients with more severe infections should initially be placed on empiric,
broad antibiotic converge until more focused therapy can be initiated on the basis of
appropriate culture results.23,31 As previously discussed, the majority of the moderate
to severe lower-extremity infections in this patient population are polymicrobial, and
considering the increasing rates of antibiotic-resistant strains of pathogens, it is vital that
these patients receive appropriate antibiotic coverage. Toward this end, it is critical that
DRRAFT members be able to effectively select appropriate empiric therapy and modify
patient’s antibiotic regimens in response to accurate culture and sensitivity data.
7. The ability to perform appropriate postoperative monitoring to reduce risks of
reulceration and infection.
Justbecauseinitialwoundhealinghasbeenachieveddoesnotguaranteethatthebattleis
yet won. Diabetic patients with previous ulceration are at significantly increased risk for
reulceration.35,36ItisnecessarythatDRRAFTmembershavetheabilitytoactivelyfollow
these high-risk patients throughout the post–wound healing phase. DRRAFT members
should utilize the ADA Foot Risk Classification System, which quantifies patients into
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risk groups on the basis of vascular status, potential LOPS, as well as the presence or
absence of deformity, and then makes treatment and follow-up recommendations on
the basis of increasing levels of risks (Fig 3).10,37 Patients with history of ulceration or
amputation are considered to be in risk group 3 and require stringent follow-up every 1
to2monthsforprophylacticevaluation.Inaddition,thepostulcerativepatientsshouldbe
encouraged to evaluate their lower-extremity skin temperatures via dermal thermometer
daily at home because studies have demonstrated that skin temperatures significantly
increase before skin breakdown actually occurs.38 In this way, these high-risk patients
can monitor themselves and titrate their activity accordingly.
CONCLUSION
As the population ages and lifestyles change, the incidence and prevalence of diabetes mel-
litus are increasing, and therefore it is incumbent upon clinicians involved in the care of
patients with diabetes to be adequately prepared to provide efficient, quality care to pre-
vent lower-extremity ulceration, infection, and ultimate amputation. The DRRAFT model
proposes 7 essential skills that form a necessary core of the interdisciplinary limb salvage
model. These skills provide for the rapid diagnosis and timely surgical management of dia-
betic patients with lower extremity compromise and should be the foundation upon which
any interdisciplinary team be built.
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